Evaluation of growth, puberty, osteoporosis, and the response to long‐term bisphosphonate therapy in four patients with osteoporosis‐pseudoglioma syndrome-Reference-Cited by-同舟云学术

Evaluation of growth, puberty, osteoporosis, and the response to long‐term bisphosphonate therapy in four patients with osteoporosis‐pseudoglioma syndrome

Published:2022-04-08 Issue:7 Volume:188 Page:2061-2070
ISSN:1552-4825
Container-title:American Journal of Medical Genetics Part A
language:en
Short-container-title:American J of Med Genetics Pt A

Author:

Karakilic‐Ozturan Esin¹^ORCID,Altunoglu Umut²³^ORCID,Ozturk Ayse Pinar¹^ORCID,Kardelen Al Asli Derya¹^ORCID,Yavas Abali Zehra¹^ORCID,Avci Sahin³^ORCID,Wollnik Bernd⁴,Poyrazoglu Sukran¹^ORCID,Bas Firdevs¹^ORCID,Uyguner Zehra Oya²^ORCID,Kayserili Hülya³^ORCID,Darendeliler Feyza¹^ORCID

Affiliation:

1. Istanbul Faculty of Medicine, Department of Pediatrics, Pediatric Endocrinology Unit Istanbul University Istanbul Turkey

2. Istanbul Faculty of Medicine, Department of Medical Genetics Istanbul University Istanbul Turkey

3. Department of Medical Genetics Koc University, School of Medicine Istanbul Turkey

4. University Medical Center Göttingen, Institute of Human Genetics Göttingen Germany

Publisher

Wiley

Subject

Genetics (clinical),Genetics

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajmg.a.62742

Reference41 articles.

1. Clinical and Molecular Findings in Osteoporosis-Pseudoglioma Syndrome

2. Alendronate treatment in children with osteogenesis imperfecta;Akçay T.;Indian Pediatrics,2008

3. Three Years Follow-up of Pamidronate Therapy in Two Brothers with Osteoporosis-Pseudoglioma Syndrome (OPPG) Carrying an LRP5 Mutation

4. Effects of 3 Years of Intravenous Pamidronate Treatment on Bone Markers and Bone Mineral Density in a Patient with Osteoporosis-Pseudoglioma Syndrome (OPPG)

5. High Bone Density Due to a Mutation in LDL-Receptor–Related Protein 5

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical features, treatment, and follow-up of OPPG and high-bone-mass disorders: LRP5 is a key regulator of bone mass;Osteoporosis International;2024-04-16

2. LRP5, Bone Mass Polymorphisms and Skeletal Disorders;Genes;2023-09-23

3. Evaluation of Children with Secondary Osteoporosis: A Single-center Experience;Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy;2023-03-23